Since mutated p53 was highly expressed in high malignancies and reported as an oncogene gaining new activities (68, 69), we assigned the CRC cell lines to two groups (wild-type or low expression of mutated p53 versus high expression of mutated p53, median level was chosen as cutoff value; Figure 7C). This evidence concerns the gene TP53 and colorectal carcinoma.